Compare Baker Hughes Co (BKR) vs BioNTech SE - ADR (BNTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Baker Hughes Co vs BioNTech SE - ADR — how do they compare? Baker Hughes Co trades at $64.7 (market cap $64.34B), while BioNTech SE - ADR trades at $92.8 (market cap $23.31B). The key difference: Baker Hughes Co is far larger — about 2.8× BioNTech SE - ADR's market cap, and Baker Hughes Co pays a 1.42% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BKR | BNTX | |
|---|---|---|
Market Cap | $64.34B | $23.31B |
Sector | Energy | Health |
52-Week High | $69.67 | $119.34 |
52-Week Low | $42.51 | $83.89 |
Enterprise Value | $64.86B | $6.60B |
Dividend Yield | 1.42% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Baker Hughes Co
Baker Hughes is a global leader in oilfield services and oilfield equipment, with particularly strong presences in the artificial lift, specialty chemicals, and completions markets. The other half of its business focuses on industrial power generation, process solutions, and industrial asset management, with high exposure to the liquid natural gas market specifically, as well as broader industrials end markets.
Read more on BKR →About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →
